Mediaboss Marketing

News Argonne researchers trace the development of an HIV antibody that could lead to a vaccine for the virus.

Cutting-edge research at UChicagos Argonne National Laboratory is a potential first step to the development of an HIV vaccine. The research, focused on mapping the development of the CH103 antibody, was a collaborative effort, bringing together analysis conducted at Los Alamos National Laboratory and experiments conducted at Argonne.

The natural antibody CH103 is able to neutralize multiple strains of HIV, making it a uniquely effective and adaptive virus killer. By examining the formation and evolution of the antibody in relation to the virus, scientists can better understand how to reproduce the antibody in a vaccine.

HIV1 is a master of disguise, and it is very difficult for the human immune system to make antibodies that effectively neutralize diverse HIV1 isolates. The CH103 antibody is pretty good as a neutralizer, said Doctor Peter Kwong (A.B. 85, S.M. 85), who led Argonnes efforts in the research. Kwong works in the Structural Biology section of the National Institute of Healths Vaccine Research Center.

In order to conduct the study, the researchers acquired samples from an HIVpositive donor starting from the time of infection, allowing the group to obtain information about the progress of the virus and the evolution of the antibody.

Today, Kwongs research group studies the conditions, on an atomic level, that trigger the creation of CH103 antibodies.

Understanding the development of the CH103 antibody is a significant first step toward developing an HIV vaccine, though the complete creation of a vaccine is probably years down the road.

Originally posted here:
Argonne works for HIV vaccine

May 23, 2013 The known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have shown recently that another, more promising, approach is to focus on improving drugs that boost the bodys natural flu killer system.

Emergence of new influenza strains, such as the recent avian influenza (H5N1) and swine influenza (H1N1 2009), can lead to the emergence of severe pandemics that pose a major threat to the entire world population. Recently, the concern regarding the emergence of such a pandemic arose when a new and deadly avian influenza strain (H7N9) was discovered in China, causing the death of six people in only one month.

The bodys immune system can fight influenza infection. Natural killer (NK) cells, which are an essential component of this system, can recognize and eliminate influenza-virus-infected cells and inhibit the spread of the virus in the respiratory system.

But, as Ph.D. student Yotam Bar-On and Ofer Mandelboim, the Dr. Edward Crown Professor of General and Tumor Immunology at the Institute for Medical Research Israel Canada (IMRIC) of the Hebrew University Faculty of Medicine, have revealed in a paper published in Cell Reports, the influenza virus is able to escape from the NK cells activity, allowing it to spread in the respiratory system.

They show that this is accomplished by the influenza virus utilizing the enzymatic activity of the neuraminidase protein to neutralize the NK cells' receptors that are responsible for detecting the influenza-virus-infected cells. This, in effect, neutralizes the NK cells ability to accomplish their designated flu-killing duty.

With the aid of the neuraminidase protein, the influenza virus is free to exit from the infected cell, enabling it to infect new neighbor cells and spread in the respiratory system. Anti-flu drugs were developed to inhibit this spread of the virus by inhibiting the neuraminidase enzymatic activity. But, as with other, earlier anti-influenza drugs, the flu viruses are able to gain the upper hand. The extensive use of neuraminidase inhibitors has caused the emergence of new, drug-resistant influenza strains.

For example, during the spread of the swine influenza pandemic in 2009, the Health Protection Agency in the UK reported that 99% of the viruses analyzed were resistant to these inhibitors. It was shown that the virus was able to change the neuraminidase structure so the drug can no longer bind this protein, and therefore the desired inhibitory effect is lost.

But, despite this, Bar-On and Mandelboim have shown that this type of widely used drug has the effect of boosting the activity of the NK cells, enabling them to better eliminate the influenza virus. They stress, therefore, that efforts should be focused on developing effective new drugs that would maintain and enhance this NK cell activity, thereby leading to more effective elimination of the influenza virus and better recovery from flu infection without the susceptibly to the changes in the neuraminidase protein structure currently brought about by mutating flu viruses.

Excerpt from:
Boosting body's natural flu killers as way to offset virus mutation problem

(05-24 10:01)

The killer H7N9 strain of bird flu can spread among ferrets and could do the same among humans under certain conditions, according to lab animal studies on the virus published yesterday. So far there have been no known cases of human-to-human spread of the new virus, which has infected 131 people and killed 36 since it first emerged in China in March. If the virus were found to be able to spread easily among humans, experts fear it could trigger a widespread pandemic. Animal studies are a first step toward understanding how easily the virus might spread in people, AFP reports. The emerging human H7N9 influenza is infectious and transmissible in mammals,'' said the study in the US journal Science led by researchers at Shantou University, the University of Hong Kong and co-authored by colleagues in the US and Canada. Under appropriate conditions, human-to-human transmission of the H7N9 virus may be possible,'' the study added. Scientists infected lab ferrets with a sample of H7N9 taken from one of the people who died from it, and found that the virus spread among ferrets in direct contact, said the report. The virus was also found to be transmissible by air, though just one of the three ferrets tested became ill in this way. The study also tested pigs, which are considered even closer than ferrets to humans, and found that pigs could become infected but that they did not pass the virus to each other. If the study has shown that one pig had easily infected another pig, then I would be more concerned,'' said Anthony Fauci, head of the US National Institute of Allergy and Infectious Diseases. Fauci, who was not involved in the research, said the findings should be interpreted with caution. Under very experimental circumstances, one mammal can infect another one by direct contact,'' he told AFP. Saying that we are now in a greater danger of a pandemic is probably an exaggeration,'' he added. ``It's obviously something we need to keep an eye on to make sure we understand the virus better.'' Ferrets that were infected did not show symptoms of illness right away, even though they had the virus in their nasal secretions, which the study authors noted was typical in pandemic and seasonal influenza. After the infected animals were autopsied, the virus was found to be replicating in the upper as well as the lower respiratory tract, and viral RNA was detected in the ferrets' trachea, lungs, lymph nodes and brains. ``It seemed significant to me that that much virus is reaching the brain,'' said Suresh Mittal, a bird flu expert and professor of comparative pathology at Purdue University. Mittal, who was not involved in the research, said that it is not unusual for certain highly pathogenic viruses to reach the brain, but it is not often seen in human flu pandemics and more research is needed. Physicians will be more careful looking at patients and seeing if patients develop signs of encephalitis or not,'' he told AFP. Some symptoms might include confusion, dizziness, severe headache and neck pain, he said. Overall, Mittal said the study appeared to be well done and offered important signs about the transmissibility of the virus. ``The virus seems dangerous because it does infect humans and even in the pigs the virus comes out in nasal secretions,'' he said. The main thing is how to keep this away from the pig, which is a mixing vessel.'' He said that poultry and pig farms are typically kept separate in North America and Europe, lowering the likelihood that an avian influenza could emerge and jump to a pig host and eventually infect humans. But in China they may not be separate, so there the chances of getting the avian virus from poultry into pigs is much easier,'' he said.

See more here:
(H7N9 watch) Killer virus spreads in mammals, transmits by air

Top AIDS scientists were optimistic Wednesday of finding a cure for the disease that has claimed 30 million lives -- but said it might not work for all people.

The experts have high hopes for a treatment that will be given at an early stage of infection -- most likely a cocktail that includes an immunity booster and a virus killer.

But they said people with a long-running, untreated infection and a compromised immune system may never benefit from an envisioned "functional cure" -- which means a person retains traces of the virus but no symptoms.

"We have had some very interesting little lights at the end of the tunnel in individual studies," Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, said on the sidelines of a Paris conference to mark the 30th anniversary of the discovery of HIV, the virus that causes AIDS.

"It is a difficult road, but a feasible road," he said.

Proof of vaccine feasibility lay with a Thai study dubbed RV144, which in 2009 demonstrated protection for 31 percent of some 16,000 people given an experimental vaccine, said Fauci.

"I think we will likely have a (vaccine that works at) better than 31 percent, but there's certainly the possibility that we won't have a 90 percent," Fauci told reporters.

"And I think there is even a greater possibility that we won't have a pristine cure that would essentially cure everybody who is HIV infected.

"I think it's not only possible that that won't happen -- I think it is likely that that won't happen."

Fauci and other scientists point to the difficulties they have encountered to completely expunge the virus that destroys the immune system and exposes infected people to pneumonia, TB, and other opportunistic disease.

View original post here:
AIDS scientists optimistic of AIDS cure, for some

TOP AIDS scientists are optimistic of finding a cure for the disease that has claimed 30 million lives, but say it might not work for all people.

The experts have high hopes for a treatment that will be given at an early stage of infection, most likely a cocktail that includes an immunity booster and a virus killer.

But they said people with a long-running, untreated infection and a compromised immune system may never benefit from an envisioned "functional cure", which means a person retains traces of the virus but no symptoms.

"We have had some very interesting little lights at the end of the tunnel in individual studies," Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, said on the sidelines of a Paris conference to mark the 30th anniversary of the discovery of HIV, which causes AIDS.

"It is a difficult road, but a feasible road," he said.

Proof of vaccine feasibility lay with a Thai study dubbed RV144, which in 2009 demonstrated protection for 31 per cent of some 16,000 people given an experimental vaccine, said Fauci.

"I think we will likely have a (vaccine that works at) better than 31 per cent, but there's certainly the possibility that we won't have a 90 per cent," Fauci told reporters.

"And I think there is even a greater possibility that we won't have a pristine cure that would essentially cure everybody who is HIV infected.

"I think it's not only possible that that won't happen, I think it is likely that that won't happen."

A team of scientists at Monash University in Melbourne, Australia, is experimenting with an anti-cancer drug to flush the virus out of its hiding place, then to be killed.

Link:
Scientists optimistic of AIDS cure